Quadrant Management, a US-based fund, led a $45m Series C funding round in Wandercraft, a developer of a self-balancing, hands-free walking exoskeleton, with participation from Bpifrance, MACSF, Malakoff Humanis, AG2R La Mondiale, Mutuelles Impact, Sofiouest, Xange, Eurazeo, LBO France and Cemag Invest. “We are super excited to have attracted world-class investors from the USA and Europe to advance the development program of the company. With the support of patients, medical professionals and the DeepTech community, Wandercraft’s team has created a unique technology that improves rehabilitation care and will soon enable people in wheelchairs to regain autonomy and improve their everyday health," Matthieu Masselin, Wandercraft CEO.